SOLUFLEX LINK Trademark

Trademark Overview

On Thursday, January 9, 2025, a trademark application was filed for SOLUFLEX LINK with the United States Patent and Trademark Office. The USPTO has given the SOLUFLEX LINK trademark a serial number of 98947194. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Thursday, April 9, 2026. This trademark is owned by LOTTE BIOLOGICS CO., LTD.. The SOLUFLEX LINK trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical drug development services; biomedical research services; development of biotechnology relating to antibody drug conjugates; design of biologics relating to antibody drug conjugates; industrial process product development relating to antibody drug conjugates; product development for others relating to antibody drug conjugates
soluflex link

General Information

Serial Number98947194
Word MarkSOLUFLEX LINK
Filing DateThursday, January 9, 2025
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateThursday, April 9, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 28, 2026

Trademark Statements

Pseudo MarkSOLUTION FLEX LINK; SOLU FLEX LINK
Goods and ServicesPharmaceutical drug development services; biomedical research services; development of biotechnology relating to antibody drug conjugates; design of biologics relating to antibody drug conjugates; industrial process product development relating to antibody drug conjugates; product development for others relating to antibody drug conjugates

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, January 9, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameLOTTE BIOLOGICS CO., LTD.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressSongpa-gu, Seoul 05551
KR

Trademark Events

Event DateEvent Description
Thursday, January 9, 2025NEW APPLICATION ENTERED
Wednesday, April 30, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, June 18, 2025ASSIGNED TO EXAMINER
Wednesday, July 2, 2025NON-FINAL ACTION WRITTEN
Wednesday, July 2, 2025NON-FINAL ACTION E-MAILED
Wednesday, July 2, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, August 26, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, August 26, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 26, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, September 16, 2025NON-FINAL ACTION WRITTEN
Tuesday, September 16, 2025NON-FINAL ACTION E-MAILED
Tuesday, September 16, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, October 30, 2025EXAMINERS AMENDMENT -WRITTEN
Thursday, October 30, 2025EXAMINERS AMENDMENT E-MAILED
Thursday, October 30, 2025NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, October 30, 2025EXAMINER'S AMENDMENT ENTERED
Thursday, October 30, 2025SUSPENSION LETTER WRITTEN
Thursday, October 30, 2025LETTER OF SUSPENSION E-MAILED
Thursday, October 30, 2025NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, March 25, 2026TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Tuesday, March 31, 2026ASSIGNED TO LIE
Tuesday, March 31, 2026CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, March 31, 2026TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, April 2, 2026APPROVED FOR PUB - PRINCIPAL REGISTER

Related Keywords

link soluflex drug conjugates antibody relating development services product industrial process others